ZONGXIANG, CHEN – Trademark Portfolio

Entity Type: 01

ZONGXIANG, CHEN holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 7 (Machinery) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include BLIBLITEC and ESKIMOTEC. The owner is based in SHANGRAO CITY.

ROOM 101, UNIT 1, NO. 107 TANGJIA LANE

YIJIANG TOWN, YIYANG COUNTY

SHANGRAO CITY 334400 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ZONGXIANG, CHEN's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

7
Machinery (1 filing)

Machines and machine tools; motors and engines; machine coupling and transmission components

Frequently Asked Questions

How many trademarks does ZONGXIANG, CHEN have?

ZONGXIANG, CHEN has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does ZONGXIANG, CHEN file in?

ZONGXIANG, CHEN files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 7 (Machinery). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are ZONGXIANG, CHEN's most well-known trademarks?

ZONGXIANG, CHEN's registered trademark portfolio includes well-known marks such as BLIBLITEC and ESKIMOTEC. These are among 2 currently registered trademarks in the portfolio.

What is ZONGXIANG, CHEN's trademark registration success rate?

ZONGXIANG, CHEN has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.